
Our client had a specific need to develop and build a highly effective team of key account managers (KAMs) and Medical Science Liaisons (MSLs) in the UK and EU4 with experience and expertise in the relevant rare disease areas.
Following in-depth scoping meetings, Inizio Engage worked closely with the client to define the optimum levels of support for commercial endeavors as well as providing KOLs with peer-to-peer level medical expertise.
Recruiting MSLs with the appropriate background can be a challenge for any business – we delivered on this in the key European markets in time for pre-launch activities.
Inizio Engage recruited and trained KAMs with the appropriate experience and educational background to focus on specific targeted physicians in the rare disease space.
We provided the in-country infrastructure along with the above-country governance, without the need for the client to build in-house infrastructure in each market.
The partnership continues to be a success, in some countries so successful that individuals initially employed by Inizio Engage have been taken in-house.
Jump to a slide with the slide dots.
Discover how Inizio Engage helped a rare disease biotech reduce commercial launch risk through HCP mapping, referral pathway analysis and...
Read more
Discover how AI, customer experience, and intelligent field teams are reshaping HCP engagement strategies across the pharmaceutical product lifecycle.
Read more
Discover how learning systems, AI, and continuous optimisation are transforming pharmaceutical commercial strategy and HCP engagement.
Read more
Inizio Engage expands its Global Medical Information capabilities with Connected Insights, combining AI, global expertise and...
Read more